Preface | p. xv |
Acknowledgements | p. xvii |
Abbreviations and symbols | p. xix |
The causes of psychosis | |
Introduction | p. 3 |
The definitions of psychosis | p. 3 |
Scope and threshold for inclusion | p. 3 |
Emphasis on non-psychiatric phenotype in diagnosing secondary psychosis, and on psychopathology in diagnosing primary psychosis | p. 4 |
Two useful approaches to the diagnosis of psychosis | p. 5 |
Arrangement of this book | p. 5 |
Methods | p. 6 |
Delirium | p. 7 |
Causes | p. 7 |
Exclusion | p. 8 |
Neurodevelopmental disorders and chromosomal abnormalities | p. 10 |
Velocardiofacial syndrome | p. 10 |
Trisomy 21 | p. 11 |
Other chromosomal abnormalities | p. 11 |
Agenesis of the corpus callosum | p. 12 |
Prader-Willi syndrome | p. 12 |
Phenylketonuria | p. 13 |
X-linked mental retardation syndromes | p. 13 |
Other rare genetic conditions presenting early in life | p. 13 |
Other rare neurodevelopmental disorders | p. 15 |
Neurodegenerative disorders | p. 16 |
Alzheimer's disease | p. 16 |
Vascular dementia | p. 17 |
Parkinson's disease and ôParkinson's plusö syndromes | p. 17 |
Dementia with Lewy bodies | p. 18 |
Asymmetric cortical degeneration syndromes, including frontotemporal dementia and Pick's disease | p. 18 |
Motor neuron disease | p. 19 |
Huntington's disease | p. 20 |
Dentatorubropallidoluysian atrophy | p. 21 |
Spinocerebellar ataxia | p. 21 |
Neuroacanthocytosis | p. 21 |
Basal ganglia calcification | p. 22 |
Pantothenate kinase-associated neurodegeneration | p. 22 |
Neuroferritinopathy | p. 23 |
Argyrophilic grain disease | p. 23 |
Thalamic degeneration | p. 24 |
Other rare genetic conditions presenting late in life | p. 24 |
Focal neurological disease | p. 25 |
Cerebrovascular disease | p. 25 |
Epilepsy | p. 27 |
Classification of seizures | p. 27 |
Psychosis and epilepsy | p. 28 |
EEG features of relevance and underlying causes | p. 31 |
Migraine | p. 31 |
Hypertensive encephalopathy and posterior reversible encephalopathy syndrome | p. 33 |
Head injury (traumatic brain injury) | p. 33 |
Normal-pressure hydrocephalus | p. 34 |
Intracranial mass lesions (tumours) and obstructive hydrocephalus | p. 34 |
Multiple sclerosis | p. 35 |
Central pontine and extrapontine myelinolysis | p. 36 |
Tuberous sclerosis | p. 36 |
Malignancy | p. 38 |
Infectious and postinfectious syndromes | p. 40 |
Bacterial infection | p. 41 |
Pyogenic bacterial infection | p. 41 |
Neurosyphilis | p. 41 |
Lyme disease (borreliosis) | p. 42 |
Bartonella infection | p. 44 |
Leptospirosis | p. 44 |
Tuberculosis | p. 44 |
Brucellosis | p. 45 |
Whipple's disease | p. 46 |
Other systemic bacterial infections with prominent neuropsychiatric effects | p. 47 |
Viral infection | p. 48 |
Herpesvirus encephalitis | p. 49 |
HIV encephalitis and AIDS dementia | p. 51 |
Other acute viral encephalitides | p. 52 |
Other subacute viral encephalitides | p. 53 |
Protozoal infection | p. 54 |
Malaria | p. 54 |
Toxoplasmosis | p. 54 |
Trypanosomiasis | p. 55 |
Fungal infection (mycosis) | p. 56 |
Eosinophilic meningitis and meningoencephalitis, helminths, and macroparasites | p. 56 |
Protein infection: Creutzfeldt-Jakob disease and other prion diseases | p. 57 |
Autoimmune disease following infection | p. 58 |
Sydenham's chorea and PANDAS | p. 58 |
Encephalitis lethargica | p. 59 |
Postinfectious encephalomyelitis and acute disseminated encephalomyelitis | p. 59 |
Endocrine disease | p. 60 |
Hypothyroidism and hyperthyroidism | p. 60 |
Glucocorticoid excess | p. 63 |
Adrenal failure | p. 64 |
Hypopituitarism | p. 65 |
Hypoparathyroidism and hyperparathyroidism | p. 65 |
Sex hormones and psychosis | p. 66 |
Schizophrenia and sex hormones | p. 66 |
Puerperal (postpartum) psychosis and other oestrogen withdrawal states | p. 66 |
Other relationships between sex hormones and psychosis | p. 67 |
Inborn errors of metabolism | p. 68 |
Hyperammonaemia and urea cycle disorders | p. 68 |
Porphyria | p. 69 |
Disorders of amino acid metabolism | p. 71 |
Hereditary tyrosinaemia | p. 71 |
Hyperhomocysteinaemia and homocystinuria | p. 71 |
Hartnup's disease | p. 72 |
Maple syrup urine disease | p. 72 |
Wilson's disease | p. 73 |
Storage diseases | p. 74 |
Neuronal ceroid lipofuscinosis | p. 74 |
Niemann-Pick disease, type C | p. 74 |
Hexosaminidase deficiency (GM2 gangliosidosis) | p. 75 |
Mucopolysaccharidosis | p. 75 |
Fabry's disease | p. 76 |
Aspartylglucosaminuria | p. 76 |
Metachromatic leukodystrophy | p. 77 |
X-linked adrenoleuko-dystrophy | p. 77 |
Cerebrotendinous xanthomatosis | p. 78 |
Alpha-mannosidosis | p. 78 |
Krabbe's disease (globoid cell leukodystrophy) | p. 79 |
Gaucher's disease | p. 79 |
Vanishing white matter leukoencephalopathy | p. 80 |
Diffuse sclerosis | p. 80 |
Mitochondrial encephalopathies | p. 80 |
Glucose-6-phosphate dehydrogenase deficiency | p. 81 |
Nutritional deficiency | p. 82 |
Thiamine (vitamin B1) deficiency | p. 82 |
Niacin (vitamin B3, nicotinic acid) deficiency | p. 83 |
Pyridoxine (vitamin B6) deficiency | p. 84 |
Cobalamin (vitamin B12) deficiency, and methylmalonic aciduria | p. 85 |
Folate (vitamin B9) deficiency | p. 87 |
Zinc deficiency | p. 88 |
Omega-3 fatty acids | p. 88 |
Starvation | p. 88 |
Other acquired metabolic disorders | p. 89 |
Global cerebral hypoxia | p. 89 |
Disturbances of pH and hypercapnic encephalopathy | p. 89 |
Hypoglycaemia | p. 90 |
Organ failure | p. 91 |
Renal failure | p. 91 |
Hepatic encephalopathy | p. 92 |
Pancreatic encephalopathy | p. 93 |
Reye's syndrome | p. 93 |
Electrolyte disturbances | p. 94 |
Hyponatraemia | p. 94 |
Hypernatraemia | p. 95 |
Hypocalcaemia | p. 95 |
Hypercalcaemia | p. 96 |
Hypokalaemia | p. 96 |
Hypomagnesaemia | p. 97 |
Hypophosphataemia | p. 97 |
Autoimmune rheumatic disorders and vasculitides | p. 99 |
Connective tissue disorders | p. 99 |
Systemic lupus erythematosus | p. 99 |
Antiphospholipid syndrome | p. 102 |
Sjögren's syndrome | p. 102 |
Systemic sclerosis | p. 103 |
Mixed connective tissue disease | p. 103 |
Vasculitis | p. 103 |
Giant cell (temporal) arteritis | p. 104 |
Primary CNS angiitis | p. 105 |
Polyarteritis nodosa | p. 105 |
ANCA-associated small-vessel vasculitides | p. 106 |
Other forms of CNS vasculitis | p. 108 |
Behçet's disease | p. 109 |
Reiter's disease (reactive arthritis) | p. 109 |
Sarcoidosis | p. 109 |
Scleromyxoedema | p. 111 |
Thrombotic thrombocytopenic purpura | p. 111 |
Hyperviscosity and cryoglobulinaemia | p. 111 |
Other autoimmune encephalopathies | p. 113 |
Hashimoto's encephalopathy | p. 113 |
Autoimmune limbic encephalopathy, including paraneoplastic limbic encephalitis | p. 113 |
Antibodies against voltage-gated potassium channels | p. 114 |
Antibodies against NMDA glutamate receptors | p. 115 |
Other antibodies against neuropil and neuronal surface proteins | p. 116 |
Other antibodies against intraneuronal antigens | p. 116 |
Non-vasculitic autoimmune inflammatory meningoencephalitis | p. 116 |
Poisoning | p. 118 |
Therapeutic drugs | p. 118 |
Serotonin syndrome | p. 124 |
Recreational drugs, drugs of abuse, and withdrawal states | p. 125 |
Anticholinergic poisoning | p. 129 |
Animal, plant, and fungus poisoning | p. 129 |
Spider venom (neurotoxic araneism) | p. 129 |
Amphibian venom | p. 129 |
Fish poisoning (ichthyoallyeinotoxism) | p. 130 |
Plant and fungus poisoning | p. 130 |
Metal and metalloid poisoning | p. 131 |
Mercury (Hg) poisoning | p. 131 |
Arsenic (As) poisoning | p. 132 |
Thallium (TI) poisoning | p. 132 |
Lead (Pb) poisoning | p. 133 |
Manganese (Mn) poisoning | p. 134 |
Copper (Cu) poisoning | p. 134 |
Aluminium (AI) poisoning | p. 135 |
Bismuth (Bi) poisoning | p. 135 |
Molybdenum (Mo) poisoning | p. 135 |
Poisoning by other organic and non-metallic substances | p. 135 |
Carbon monoxide (CO) poisoning | p. 136 |
Poisoning by other organic compounds | p. 136 |
Sleep disorders | p. 140 |
Sensory deprivation and impairment | p. 142 |
Miscellaneous | p. 143 |
Coeliac disease | p. 143 |
Idiopathic hypereosinophilic syndrome | p. 144 |
Idiopathic intracranial pachymeningitis | p. 144 |
Irradiation | p. 144 |
Serine- and glycine-evoked psychosis | p. 144 |
Atrial myxoma | p. 145 |
Tinnitus | p. 145 |
Radio reception | p. 145 |
Catatonia | p. 146 |
Definition | p. 146 |
Malignant catatonia and neuroleptic malignant syndrome | p. 147 |
Other catatonic syndromes | p. 148 |
Mimics and causes of catatonia | p. 148 |
Agitation and bizarre behaviour | p. 151 |
Primary psychiatric disease | p. 152 |
Schizophrenia (F20) | p. 152 |
Manic psychosis (psychotic mania) | p. 155 |
Depressive psychosis (psychotic depression) | p. 156 |
Schizoaffective disorders (F25) | p. 157 |
Other affective psychoses | p. 157 |
Schizotypal disorder (F21) | p. 157 |
Persistent delusional disorder (F22) | p. 158 |
Acute and transient psychotic disorders (F23) | p. 159 |
Induced delusional disorder (F24) | p. 160 |
Obsessive-compulsive disorder (F42) | p. 160 |
Panic attacks with psychotic features | p. 161 |
Post-traumatic stress disorder (F43.1) | p. 161 |
Psychosis in the context of eating disorders (F50) | p. 161 |
Psychotic and near-psychotic phenomena in the context of personality disorder | p. 161 |
Paranoid personality disorder (F60.0) | p. 162 |
Schizoid personality disorder (F60.1) | p. 162 |
Emotionally unstable personality disorder, borderline type (F60.31) | p. 162 |
Chronic hallucinatory psychosis and other nonorganic psychotic disorders (F28) | p. 163 |
Unspecified nonorganic psychosis (F29) | p. 163 |
Late-onset psychosis | p. 163 |
Conditions labelled as ôpsychoticö historically | p. 164 |
Bereavement | p. 165 |
Normal and prodromal symptoms | p. 165 |
Pseudohallucinations | p. 165 |
Personality and predisposition to psychosis | p. 165 |
Stress and psychosis | p. 166 |
Prodromes and prediction of serious mental illness | p. 166 |
Factitious disorder and malingering | p. 168 |
Multiple simultaneous causes of psychosis, and questions of causality | p. 169 |
A clinical approach to the diagnosis of psychosis | |
History and examination | p. 173 |
Overview and method | p. 173 |
Probe questions for psychotic symptoms | p. 177 |
Probe questions for depression and mania | p. 180 |
Rapid exclusion of medical emergencies presenting as psychosis | p. 182 |
Initial investigations relevant to psychosis | p. 183 |
Suggested initial investigations in psychosis | p. 183 |
Clues from routine and other first-line investigations | p. 185 |
Putting it together: clinical and paraclinical clues | p. 190 |
Further investigations relevant to psychosis | p. 230 |
Classificatory approach for psychosis of unknown aetiology | p. 248 |
Classificatory approach to psychosis of unknown aetiology, based on ICD-10 | p. 249 |
ICD-10 criteria for mood disorders | p. 252 |
ICD-10 criteria for schizophrenia | p. 256 |
ICD-10 criteria for schizotypal disorder and personality disorders associated with psychotic symptoms | p. 259 |
Classifactory approach to psychosis of unknown aetiology, based on DSM-IV-TR | p. 262 |
DSM-IV criteria for mood disorders | p. 267 |
DSM-IV criteria for schizophrenia | p. 271 |
DSM-IV criteria for personality disorders associated with psychotic symptoms | p. 273 |
Examination for catatonia | p. 277 |
Fink & Taylor criteria for catatonia | p. 278 |
Conclusion | p. 279 |
Selected conditions not known to cause psychosis | p. 281 |
Relevant changes proposed in DSM-V | p. 284 |
References | p. 289 |
Index | p. 362 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.